The genae
difference
Expertise
Innovation
Scope
Partnership
Value
genae’s expertise covers a broad range of therapeutic areas. The knowledge and understanding of the specific area of your therapy or device ensures compliance and facilitates in the actual conduct of your trial.
Your advantage of working with genae is captured in our extensive experience in the central coordination and logistics of clinical research projects.
genae’s mission is to improve health and quality of life by innovating and accelerating high quality research – with a zealous dedication to safety and ethics.
With local anchoring, we aim at accelerating high-quality and cost-contained recruitment and execution of your global medical device trials.
Read more

genae updates  

 
 

edc2go webinar (July 18) - recording available!

18 July 2016

The main goal of any EDC solution is to be secure, user friendly and customized to fit your specific trial.

The ed2cgo platform is such an EDC tool with price transparency, is easy to use and a FREE 30day trial.

View this 50 min. webinar and find out how easy it is to build an eCRF with edc2go. Visit edc2go.com for more information.

VIEW THE WEBINAR HERE

Continue reading
 

genae Americas celebrates its 5th anniversary

01 July 2016

genae Americas celebrates its 5th anniversary this year.

Since 2011 we have opened offices in Cleveland, New York City & San Francisco and managed clinical trials together with over 200 sites.

Discover our geographical experience in the US here.

Continue reading
 

Insourcing or Outsourcing - Do the sums add up?

10 May 2016

Insourcing or outsourcing in clinical trials is a late-breaking topic. Despite other branches of trade such as the automotive industry where large companies are experiencing a comeback of insourcing, the conduct of clinical trials are mostly outsourced to contract research organizations (CROs). This paper tackles the benefits and challenges of both approaches and sheds light on what to take into consideration when outsourcing your clinical trial to a CRO.

Continue reading